November 20, 2007 — STUTTGART, GERMANY, and RIETI, ITALY — M+W Zander Italia S.r.I. has received its first contract for a photovoltaic (PV) plant in Italy from its Customer SOLSONICA S.p.A., a new company ensued from EEMS S.p.A. (www.eems.it), a semiconductor company acting on a global scale. M+W Zander is design and build contractor for the facility systems of an existing semiconductor manufacturing facility, which is partially being retrofit into a PV cell manufacturing plant. The scope of work extends from the installation of gas and chemical distribution systems, done in cooperation with the JV partners Air Product Italia S.r.l. and Sapio Produzione Idrogeno e Ossigeno S.r.l. to the upgrade of the electrical system, the compressed air distribution, and the demineralized water distribution plant.

SOLSONICA S.p.A. plans to manufacture polycrystal silicon solar cells on a production area of 3,500 m² and an additional 2,000 m² of service area at the Rieti site, approx. 80 km from Rome. The manufacturing facilities of EEMS S.p.A. are also located in Rieti. Production start is planned by mid-2008, annual production during the first expansion stage is 30 MWp/year.

Subsequent production expansions are already included in the plans, which will increase the plant capacity up to 120 MWp/year. Tool move-in and start and commissioning are scheduled in January 2008.

“We are very happy for this breakthrough in Italy,” says M+W Zander Italia president Robert Gattereder. “Italy is a very important market for us.” In the Spring of 2007, the market research institute EuPD Research (www.eupd-research.com) presented a study on the photovoltaic market in Italy and forecasted an increase in peak capacity of 150 MWp.

About M+W Zander
With its subsidiary and holding companies, MWZ Beteiligungs GmbH offers worldwide integrated business solutions for company facilities, high-tech production plants, and industrial complexes. Operations focus on production of cleanroom technology and facility management for the electronic, solar, pharmaceutical, chemical, and energy industries and also research institutes. In the year 2006, the M+W Zander Group generated a turnover of approximately 1.76 billion euros with a 7,200-strong workforce worldwide. M+W Zander Italia S.r.l. is a company in the globally acting M+W Zander Group.

Visit www.mw-zander.com

November 16, 2007 — /PRNewswire/ — GERMANTOWN, WI — Cambridge Major Laboratories today announced the acquisition of ChemShop B.V., Weert, the Netherlands, a European supplier of active pharmaceutical ingredient (API) development services. The newly combined company is one of the largest pharmaceutical chemistry development organizations in the western hemisphere, with over 140 employees at 3 sites in the U.S. and Europe. Carrying forward ChemShop will adopt the name Cambridge Major Laboratories Europe.

ChemShop has built an impeccable reputation in the pharmaceutical chemistry outsourcing sector, providing process development and GMP manufacturing services for the past nine years. All of ChemShop’s management and personnel will continue to operate the business at the Weert facility which includes R&D laboratories, GMP kilo lab suites, and a GMP pilot plant. The ChemShop facility provides intermediates and API’s from grams to hundreds of kilograms scale.

As part of its commitment to global operations and to support its tremendous growth, Cambridge Major will invest several million dollars to expand the European site which will include more reactor capacity, laboratories, and expansion of the company’s high potency API (“HPAPI”) manufacturing capabilities to keep the ChemShop site on a fast growth track. The planned expansion will commence immediately and be completed in the second half of 2008.

“The addition of ChemShop presents an enormous opportunity for both companies to further tap into the growing European pharmaceutical market and to penetrate deeper into the US market as we leverage our combined technical expertise and human resources,” says Michael W. Major, president and CEO, Cambridge Major Laboratories. “More importantly, both organizations share the same mentality and business approach which will guarantee seamless integration and will further bolster CML’s technological reputation and expand its global capabilities in API-related chemistry services.”

“We are excited to serve the industry together with Cambridge Major and we are convinced that the combined expertise will create a unique company able to provide even better performance than before,” says Peter Van Tilburg, CEO, ChemShop B.V. “The synergies between both companies are truly fantastic and will without any doubt result in a huge added value for our customers.”

About Cambridge Major Laboratories
Cambridge Major Laboratories, Inc. is a leading global service-based chemistry outsourcing partner to the pharmaceutical and biotechnology industries, producing pharmaceutical intermediates, active pharmaceutical ingredients, and other fine organic chemicals. The company specializes in chemical process development and advanced multi-step organic synthesis, and operates out of three facilities in the U.S. and Europe. The company has been FDA inspected and approved for cGMP manufacturing.
Source: Cambridge Major Laboratories

Visit www.c-mlabs.com

November 16, 2007 — SITTARD/LEIDEN, THE NETHERLANDS — DSM Biologics, a business unit of DSM Pharmaceutical Products and Dutch biotechnology company Crucell N.V. today announced a PER.C6(R) license agreement with Daiichi Sankyo Ltd. This license agreement allows Daiichi Sankyo to use the PER.C6(R) cell line in its early stage research to identify new antibodies and for the production of pre-clinical grade material. Financial details were not disclosed.

About the PER.C6(R) Technology Platform
Crucell’s PER.C6(R) technology platform has been developed for the large-scale manufacture of biopharmaceutical products such as recombinant proteins including monoclonal antibodies. Compared to conventional production technologies, the strengths of PER.C6(R) technology lie in its excellent safety profile, scalability, and productivity under serum-free culture conditions.

About Crucell
Crucell N.V. is a biotechnology company focused on research, development and worldwide marketing of vaccines and antibodies that prevent and treat infectious diseases. Its vaccines are sold in public and private markets worldwide. Crucell’s core portfolio includes a vaccine against hepatitis B, a fully-liquid vaccine against five important childhood diseases, and a virosome-adjuvanted vaccine against influenza. Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminium-free hepatitis A vaccine on the market. The company has a broad
development pipeline, with several Crucell products based on its unique PER.C6(R) production technology. The company licenses this and other technologies to the biopharmaceutical industry. Important partners and licensees include DSM Biologics, Sanofi Aventis, Novartis, Wyeth and Merck & Co. Crucell is headquartered in Leiden (The Netherlands), with subsidiaries in Switzerland, Spain, Italy, Sweden, Korea, and the U.S. The company employs more than a 1,000 people.

Visit www.crucell.com

About DSM Biologics
DSM Biologics, a business unit of DSM Pharmaceutical Products, is a global provider of manufacturing technology and services to the biopharmaceutical industry. In addition to offering world-class biopharmaceutical manufacturing services, DSM Biologics has co-exclusive rights, along with Dutch biotech company Crucell N.V., to license the high-producing PER.C6(R) human cell line as a production platform for recombinant proteins and monoclonal antibodies. DSM Biologics’ FDA-approved
facility in Groningen, The Netherlands, was established in 1986 and has a strong track record in using a broad range of cell lines (PER.C6(R), CHO, hybridoma, etc.) in biopharmaceutical manufacturing, and has a wide range of experience using multiple manufacturing (batch, fed-batch and continuous perfusion) and purification techniques. The combination of the PER.C6(R) human cell line and DSM’s manufacturing services provides companies with a turn-key biologic manufacturing solution reducing cost, risk and time to market. DSM Biologics is represented in Japan by Asahi Glass & Co, Ltd.

Visit www.dsmbiologics.com

About DSM
DSM creates innovative products and services in life sciences and materials sciences, contributing to the quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and enjoyable way of living. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. The company strategy, Vision 2010

November 19, 2007 — /FDA Digest/ — The U.S. Food and Drug Administration’s Office of Regulatory Affairs (ORA) today announced the award of three lab grants, designed to boost the food screening capabilities and spot radioactive material in food, resulting from deliberate or accidental contamination. These labs are part of the Food Emergency Response Network (FERN).

The three-year grants provide $250,000 a year for supplies, personnel, minor facility upgrades, and training. Recipients of the grants are the Texas Department of State Health Services Laboratory, the New York Health Research/New York Department of Health, and the Wisconsin State Laboratory of Hygiene.

FDA’s ORA will expand its testing program to address the threat to food safety through radiological terrorism events. ORA has developed radiological screening and analysis methodologies used to evaluate foods and food products.

The grants are targeted toward enhanced detection of radiological contamination and thus enhance the nation’s overall capability to rapidly detect and respond to deliberate attacks on the food supply.

The grant awards further expand the FDA’s ability to promote the integrated strategy for protecting the nation’s food supply through the three core elements of prevention, intervention, and response, as outlined in the agency’s Food Protection Plan. These funded labs will be involved in food defense surveillance testing as well as bolstering the FDA’s emergency response efforts by increasing the capacity for testing of foods for radioactive contamination, intentional or accidental.

The selected laboratories will receive funds to assist in acquiring supplies, personnel, and facility upgrades. The labs will receive training in current food testing methodologies, participate in method development and validation, proficiency testing, and food defense surveillance assignments.

Two key project areas have been identified for the grant recipients. These areas involve the detection of radioactive contamination, utilizing the most advanced detection systems available.

FERN’s mission is to integrate the nation’s food-testing laboratories at the local, state, and federal levels into a network able to respond to emergencies involving biological, chemical, or radiological food contamination. The network can respond to emergencies related to agents in food and restore the public’s confidence in the food supply.

Visit www.fda.gov

November 14, 2007 — /PRNewswire/ — CLEVELAND, OH — PolyOne Corp., a leading global provider of specialized polymer materials, services, and solutions, announced today that it has signed a definitive agreement to acquire GLS Corp. (GLS), the leading North American provider of specialty thermoplastic elastomer compounds (TPE) for consumer and medical applications. GLS has annual sales of approximately $130 million. Terms of the pending transaction were not disclosed. However, PolyOne expects that the acquisition will be slightly accretive to earnings in the first year. Consummation of the transaction is subject to the satisfaction or waiver of customary closing conditions.

GLS, a privately held company owned by the Dehmlow family, is headquartered in McHenry, IL. It has built a superb reputation as a strategic partner to many of the world’s best-known companies in developing and marketing highly customized soft TPEs. GLS products give toothbrush handles a softer touch, provide a better grip for electronic devices, create a stronger seal for food and beverage packaging, and enhance the flexibility of medical tubing systems. The company, which serves more than 1,200 customers worldwide, has achieved double-digit revenue growth in each of the last 10 years and is well positioned to capitalize on escalating demand for soft-touch products. With approximately 200 employees, GLS supports its customers with manufacturing facilities in Illinois and Suzhou, China. In 2006, GLS became the first specialty TPE compounder to begin production in China.

The potential acquisition of GLS demonstrates PolyOne’s continued commitment to executing a specialization strategy focused on technical innovation, new product launches, speed to market, and long-term customer alliances rooted in problem solving and value creation. GLS is known for difficult-to-develop specialty compounds and rapid turnaround on customer requests, with a research and development department that operates around the clock. The acquisition of GLS also will provide PolyOne access to new customers in specialized, high-growth markets such as health care and electronics. PolyOne has targeted these markets for expansion and believes there are additional cross-selling opportunities. Moreover, the two companies’ global footprints are highly complementary.

“GLS is a very important strategic acquisition and the kind of company that we have been carefully seeking to become a significant part of PolyOne’s business portfolio,” says Stephen D. Newlin, chairman, president, and CEO. “We are delighted to welcome the GLS employees and customers to the PolyOne family. The GLS management team has built a terrific brand and is a customer-centric growth company. Its people and technology will be valuable additions to the PolyOne team.”

“Combining GLS’s technological capabilities with PolyOne’s global infrastructure and commercial presence uniquely positions us to capitalize on the expanding TPE market,” Newlin adds.

Craig Nikrant, PolyOne’s vice president and general manager of PolyOne’s North American engineered materials, says, “GLS is a great addition to the global engineered materials business portfolio. This acquisition will accelerate the specialization strategy for our global Engineered Materials business and will decisively shift our portfolio as we continue our aggressive evolution into a specialty solutions provider of engineering thermoplastics. The acquisition of GLS, coupled with last year’s dedication of our $10 million specialties compounding plant, clearly demonstrates our commitment to our specialization strategy.”

“We are delighted to join forces with PolyOne and become a key component in its strategic evolution,” says Dan Dague, GLS president. “We were impressed with PolyOne’s management, its strategic vision and its corporate philosophies, and believe the combination will result in a new organization that is even stronger and better poised for future success.”

Bear, Stearns & Co. Inc. was PolyOne’s financial advisor on the GLS acquisition and Jones Day was outside counsel.

About PolyOne
PolyOne Corp., with 2006 annual revenues of $2.6 billion, is a leading global provider of specialized polymer materials, services, and solutions. Headquartered in northeast Ohio, PolyOne has operations in North America, South America, Europe, Asia, and Australia, and joint ventures in North America and South America.

Source: PolyOne Corp.

Visit www.polyone.com

November 7, 2007 — /PRWEB/ — OSLO, NORWAY — On October 15th, CAMO hosted the second of a total of seven seminars on spectroscopy and sensory around Europe. This free seminar series featuring solutions for both spectroscopy and sensory applications is organized in cooperation with various instrument partners, including Perten Instruments, Carl Zeiss, and Thermo.

More than 25 people attended the free seminar in Copenhagen, listening to the latest in both spectroscopy and sensory. The spectroscopy session covered several aspects of the workflow associated with handling spectral data and included a presentation of the MyInstrument add-on, which is one of the new features in The Unscrambler(R) 9.7. The MyInstrument add-on for The Unscrambler(R) provides users with the ability to directly acquire spectra from their spectrometers into The Unscrambler(R) software.

During the seminar, Stefan Lundgren from Perten Instruments gave a presentation of application examples where the company’s NIR instrument, Diode Array 7200 with an integrated OLUP, was used. Lundgren also arranged an analysis of items collected from the lunch buffet.

“It was great to see the level of attendance at the seminars in Oslo and Copenhagen and, of course, the interest in Perten’s instrument solutions. Given our increased cooperation with CAMO, e.g., the OLUP now being a standard feature of our Diode Array NIR instruments, we’ve come to appreciate the many features of The Unscrambler and the high quality support provided by CAMO,” says Stefan Lundgren, area sales manager for Perten in the Nordic region.

The seminar was held on the same day CAMO Software announced the launch of its new software, Quali-Sense 1.0. This software evaluates the performance of expert sensory panels using a set of statistical tests, and it helps detect the personal strengths and weaknesses of each assessor in a sensory panel.

“We are excited to announce this first release of our sensory solution along with a series of training programs across the world,” said Dr. Ingrid M

November 8, 2007 — /PRWEB/ — BURNSVILLE, MN — Gerbig Engineering, a company specializing in the design, build, installation, and certification of cleanrooms, is announcing its recent expansion into another facility. The new facility is located in North Branch, MN, where softwall cleanrooms, cleanroom workstations, and specialty equipment will be fabricated. The main cleanroom fabrication and engineering continues to be located in Burnsville, MN.

“Our significant growth over the last 18 months has driven the need to expand our facilities,” says Fred Gerbig, president of Gerbig Engineering. “With this expansion, we can adequately handle our expected growth over the next several years. In addition, we now have our facilities more specialized and should experience better efficiencies.”

Gerbig Engineering has been designing, fabricating, and installing cleanrooms since 1985. Gerbig Engineering features the AireCell Cleanroom systems; AireCell is a specialized line of aluminum and PVC extrusions and assemblies. Anodized framing is quickly created and locked together with an Allan wrench. Panels are easily installed and sealed into this framework. Walls are created in hours instead of days.

Visit www.gerbig.com

November 8, 2007 — /PRNewswire/ — WILMINGTON, MA — MKS Instruments, Inc., a leading worldwide provider of monitoring and control technologies for improving productivity in semiconductor and other advanced manufacturing processes, announced that it has acquired privately held Yield Dynamics, a provider of yield management technology based in Sunnyvale, CA. The acquisition is expected to be slightly accretive going forward and is not expected to materially affect MKS’s near term financial results.

Leo Berlinghieri, MKS’s CEO and president, says, “Semiconductor fabs need to improve yield to meet production cost targets as they transition to smaller device geometries. We see opportunities to increase our sales to semiconductor fabs with a total solution for managing and correlating process data to improve process yield. We also see long-term opportunities for our yield management solution in flat-panel display, solar cell, and other markets that use thin-film manufacturing processes.”

Yield Dynamics’ data and yield management software, along with MKS’s portfolio of sensors that control critical processes, data collection and integration hardware, and real-time fault detection and classification software, provides a comprehensive offering for generating, collecting, and analyzing process sensor data and correlating the data to wafers, chambers, and tools across the fab.

Berlinghieri continues, “By correlating real-time process chamber information with offline production analysis on wafer yield, fabs could achieve higher yield. We believe we can help fabs identify additional information from our sensors that, when integrated with fault detection and classification and yield management software, could allow fabs to take a step closer to predicting process excursions before they happen and improve yield while reducing cost.”

Jonathan Buckheit, president and CEO of Yield Dynamics, says, “We are pleased to join an industry leader with technology focused on improving process productivity, and by offering a solution-driven approach to yield improvement we expect to deliver added value.”

About MKS
MKS Instruments, Inc. is a leading worldwide provider of process control solutions for improving productivity in advanced manufacturing processes such as semiconductor device manufacturing; thin-film manufacturing for flat-panel displays, data storage media, architectural glass and electro-optical products; and technology for medical imaging equipment and other markets. The company’s instruments, components, and subsystems incorporate sophisticated technologies to power, measure, control, and monitor increasingly complex gas related semiconductor manufacturing processes, thereby enhancing our customers’ uptime, yield and throughput, and return on invested capital.

Source: MKS Instruments, Inc.

Visit www.mksinst.com

November 13, 2007 — /PRNewswire/ — MOORESVILLE, NC — Anpath Group, Inc. reported today that its wholly owned subsidiary, EnviroSystems, Inc. (ESI) announced the selection of its disinfectant EnviroTru(TM) for use by the Washington Metropolitan Area Transit Authority (Metro).

EnviroTru(TM) is a multi-purpose disinfectant and deodorizing cleaner effective against numerous organisms and also meets EPA requirements for Toxicity Category IV (no harmful dermal, ocular, inhalation, or ingestion effects). ESI reported that Metro recently placed an initial order for more than 600 gallons of the disinfectant.

“It is especially gratifying for our product/technology to be chosen by the transit system serving our nation’s capitol,” states ESI president and CEO J. Lloyd Breedlove. He continues, “EnviroTru(TM) is ideally suited for use in a transit system environment. As a result of its biocidal efficacy combined with its favorable materials compatibility and environmental profile EnviroTru(TM) is a natural choice for heavy traffic areas.”

Metro is the tri-jurisdictional government agency authorized by Congress to operate the transit service in the Washington, DC metropolitan area, including the Metrorail and Metrobus; totaling more than 11,000 rail cars, buses, and special means transport vehicles. Metro is also part of the public-private partnership that operates the DC Circulator bus system. Polly Hanson, assistant general manager of Safety, Security and Emergency Management with Metro, states, “We are pleased to have identified and selected a product with the characteristics of EnviroTru(TM). It is important that we make every effort to protect our customers and employees against the spread of infectious diseases without exposing them to harmful chemicals, while also taking into account our equipment and the environment in general.”

ESI states that in addition to daily application of EnviroTru(TM) on high hand contact areas such as door handles, hand rails, fare card machine buttons, etc., in the event of a pandemic flu or other infectious disease outbreak Metro is prepared to use EnviroTru(TM) with the Foster-Miller, Inc. Electrostatic Charged Aerosol Decontamination System (ECADS) (www.fostermiller.com/ecadsproduct.htm) to spray rail cars, buses, and other vehicles daily. ESI worked with Foster-Miller, Inc. to validate the use of its disinfectant with ECADS.

According to Foster-Miller, Inc. representative, Rick Lusignea, “Metro purchased 17 high efficiency air assisted ECADS sprayers from Foster-Miller to dispense EnviroTru(TM).” Lusignea explains, “The ECAD decontamination and remediation system disperses fine electrically charged droplets of decontaminant into the air. Because of the static charge imparted to aerosol particles, ECADS provides a much higher amount of disinfectant on surfaces than conventional air assisted spray systems, approximately 60 percent of the total disinfectant dispensed on the surface for the ECADS sprayer, versus less than 15 percent for conventional sprayers. We think the combination of our ECADS devices and the ESI disinfectant formulation is an extremely strong weapon against disease for Metro.”

About Anpath Group, Inc.
Anpath Group, Inc., through its wholly owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment, or the environment. EnviroSystems, Inc. is focused on safe infection prevention technologies that the company believes will position the company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks — both natural and man-made.

Source: Anpath Group, Inc.

Visit www.anpathgroup.com